PATENT CLAIM ANALYSIS

Application Number: 15866895
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "239100"]

Abstract:
The present disclosure relates to chimeric neurotoxins and uses thereof. In particular, provided herein are chimeric botulinum neurotoxins with altered properties and uses thereof (e.g., research, screening, and therapeutic uses).

Claim (Index 9):
The molecule of  claim 6 , wherein said molecule exhibits longer duration, higher potency, and faster cell entry and intracellular transport relative to BoNTs having light chains and heavy chains of the same subtype.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 86.0
- Lexical Diversity: 1.40741
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13131792', '11230330', '15082158', '12769754', '14347074']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7403247540383145
- 35 USC 102 Novelty (BERT): 0.5364936717527387
- Combined Prediction Score: 0.7199416458097571
- Mean Citation Score: 325.8573800000001
- Max Citation Score: 336.55664
- Similarity Product: 186.980052456646

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test